Market Research Logo

Hungary Pharmaceuticals and Healthcare Report Q2 2016

Hungary Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The Hungarian healthcare sector will continue to face challenges which will limit the country'sattractiveness to multinational pharmaceutical firms. Low wages, a rising disease burden and the migrantcrisis have caused the healthcare system to be labelled as in a critical condition.

Headline Expenditure Projections

Pharmaceuticals: HUF660.80bn (USD2.37bn) in 2015 to HUF668.00bn (USD2.28bn) in 2016; +1.1%in local currency terms and -3.5% in US dollar terms. Forecast revised downwards from last quarter.

Healthcare: HUF2.43trn (USD8.70bn) in 2015 to HUF2.47trn (USD8.43bn) in 2016; +1.6% in localcurrency terms and -3.1% in US dollar terms. Forecast revised downwards from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Hungary 2014
2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hungary 2012
2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2012
2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2012
2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2012
2020)
Prescription Drug Market
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hungary 2012
2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hungary 2012
2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hungary 2012
2020)
OTC Medicine Market Forecast
Table: Over
TheCounter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hungary 20122020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Hungary 2014
2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Hungary 2014
2020)
Industry Risk Reward Index
Central And Eastern Europe Risk/Reward Index
Hungary Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Table: OEP Reimbursement Changes, September 2014
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Hungary 2010
2015)
Table: Healthcare Personnel (Hungary 2010
2015)
Table: Healthcare Activity (Hungary 2010
2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
ResearchBased Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Egis Pharmaceuticals (Servier)
Gedeon Richter
Demographic Forecast
Table: Population Headline Indicators (Hungary 1990
2025)
Table: Key Population Ratios (Hungary 1990
2025)
Table: Urban/Rural Population & Life Expectancy (Hungary 1990
2025)
Table: Population By Age Group (Hungary 1990
2025)
Table: Population By Age Group % (Hungary 1990
2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report